Selwan M. El‐Sayed

New thiazolopyrimidine as anticancer agents: Synthesis, biological evaluation, DNA binding, molecular modeling and ADMET study

Sara T. Al‐Rashood, Shymaa S. Elshahawy, Asmaa M. El-Qaias et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer

Nadeen M. El-Ghobashy, Selwan M. El‐Sayed, Ihsan A. Shehata et al. · Scientific Reports · 2022 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthesis and effect of some new [1,2,4]triazolo[4,3-a]quinazolin-5(4H)-ones and related compounds on Ehrlich ascites carcinoma cells

Mostafa M. Ghorab, Sami G. Abdel‐Hamide, M. S. A. El‐Gaby et al. · Acta Pharmaceutica · 1999 · 20 citations

Pharmacy, Chemistry, Medicinal Chemistry +4

New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies

Samia S. Hawas, Selwan M. El‐Sayed, Perihan A. Elzahhar et al. · Bioorganic Chemistry · 2023 · 17 citations

Medicine, Medicinal Chemistry, Oncology +12

New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study

Nayera I. Mansour, Selwan M. El‐Sayed, Nadia S. El‐Gohary et al. · Bioorganic Chemistry · 2022 · 15 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16